The EU and UK Compliance Playbook for Supplement Brand Owners

A first-time brand owner who signs a manufacturing agreement often assumes, quietly and without ever testing the assumption, that the manufacturer now carries legal responsibility for whether the finished product is allowed to say what it says, in the market it ships to. That assumption is the single costliest misunderstanding in this decision journey, because it usually surfaces only once something has already gone to print or gone to market. Manufacturing capacity and compliance responsibility are two separate questions, and outsourcing an answer to the first one does not outsource an answer to the second.

Claims, on-pack labelling and market compliance remain the brand owner's responsibility in every destination market, including which national notification route applies before a product reaches shelf. A contract manufacturer supports that responsibility with a documentation set — specification confirmation, an artwork review against the destination market's requirements, a batch Certificate of Analysis issued after production — but that support is not a compliance sign-off, and it was never designed to be one. Reading the relationship this way changes what you ask for at every stage: not "will you make sure this is compliant," but "what will you give me so I can confirm it is."

This ownership question is worth settling before you write your first brief, not after your first shipment is queried at a border or your first listing is challenged by a retailer's compliance team. A brand owner who understands, from the concept stage onward, that compliance is a decision they make and document — not a service that arrives bundled with units — ends up asking sharper questions of every manufacturer they evaluate, and catches a mismatch between concept and market rules while it is still a cheap conversation rather than an expensive correction.

A useful test for whether you have genuinely accepted this ownership, rather than agreed with it in the abstract, is whether you can name — right now, without checking — which destination market your current formula concept is aimed at, and what claim you want on its front panel. If neither answer is settled yet, compliance ownership has not really started, no matter how far along the formulation conversation already is.

Most brand owners place compliance near the end of their mental sequence — somewhere after formulation, alongside artwork, just before the label goes to print. By the time compliance shows up in that sequence, though, the ingredients are chosen, the claim the brand wants on the front of pack has already shaped the marketing brief, and the format is locked. Moving compliance earlier — to sit alongside the concept decision, not after the formulation decision — is the single change that does the most to keep a launch on schedule.

A useful discipline is to write down, at the same time you write your brand concept, the destination market or markets the product will actually sell into and the general kind of claim the brand wants to make on pack. Neither answer needs to be final. What matters is that the question gets asked early enough that a formulation conversation and a compliance conversation can run in parallel, rather than compliance becoming a gate that only opens once everything else is already decided.

This is also where a brand owner's own research differs usefully from a manufacturer's documentation. A manufacturer can tell you what a formula contains and supply the paperwork a destination market typically expects. Whether a specific claim, ingredient or format is viable in a specific market is a brand-owner-and-specialist-adviser question, informed by that documentation rather than answered by it. Treating the two as complementary, rather than assuming one replaces the other, is what keeps a compliance question from being discovered for the first time at the label-printing stage.

Almost every EU or UK market entry eventually runs into some version of the word "notification" — a step, required by a member state's national authority, that a food business must complete before a product, or in some cases a specific ingredient within it, is placed on that market. The exact form this takes, and exactly when it is triggered, differs by ingredient category, by product format and by member state, which is precisely why this guide treats it as a doctrine to be aware of, rather than a form to fill in here.

What is worth carrying into every brief is the shape of the decision, not the paperwork itself: notification is a market-by-market, sometimes ingredient-by-ingredient question, it sits with the brand owner, or whoever the brand owner nominates as the responsible food business operator, rather than with the manufacturer, and it is a step to plan time around rather than a checkbox to discover late. A brand owner who treats notification as background noise until a launch date is close usually discovers it at the worst possible moment — after the artwork is finished and the marketing calendar is already public.

It also helps to separate two questions that get bundled together in most first-time briefs: whether an ingredient or product needs a notification at all, and which specific national authority that notification goes to. The first question has a doctrine-level answer worth carrying everywhere; the second is exactly the kind of per-market detail this pillar deliberately leaves to country-specific guidance, rather than trying to compress dozens of national processes into a single section.

Because the specific notification requirement changes by destination and by ingredient, the practical move is to build the question into your own market-entry checklist rather than trying to memorise every national variation. Our country-by-country notification guidance exists precisely because a rule that is settled for one member state is not automatically settled for the next one, and a brand entering two or three EU markets at once should expect to run this check more than once, not assume the first answer travels.

It is tempting to treat "EU compliant" as a single destination you either reach or do not, the way a brand might treat a shipping zone as one line on a map. Compliance inside the EU works differently: the health-claims framework and the novel food framework are harmonised at union level, but notification routes, language requirements and elements of enforcement sit with each member state's own national authority. A product cleared for one member state has cleared review for that member state — not for the union as a whole.

This matters most at the exact moment a brand owner is deciding which EU markets to enter first, because the honest answer to "are we compliant in the EU" is almost always "compliant for which markets, specifically." A brand launching into two or three EU countries in the same production run should expect the label review, the notification step and even the accepted claim wording to need a fresh check per market, not a single review that quietly covers all of them.

The practical response is to pick your first two or three destination markets deliberately, the same way you would pick a first retail channel, rather than treating "the EU" as an undifferentiated single market you enter all at once. A smaller, deliberately chosen set of markets, checked properly, moves faster than a wide launch that assumes one clearance travels everywhere it would be convenient for it to travel.

A brand selling into both the UK and the EU is operating under two systems that no longer move together automatically. Since the UK's departure from the EU regulatory framework, a decision made by an EU authority does not automatically apply in Great Britain, and a UK-specific decision does not automatically apply back into the EU. Treating "UK and EU" as one compliance question, because the two markets sat inside one framework for years, is one of the more common assumptions this guide exists to correct.

In practice this means a brand entering both markets should expect two separate notification and labelling reviews, not one review with a UK addendum attached at the end. A health claim accepted on one side of the Channel is not automatically accepted on the other, and a novel food decision reached under one system is a starting point for the other system's own review, not a substitute for it. Building both reviews into your timeline from the outset avoids discovering, mid-launch, that "UK and EU" was never a single destination.

The sequencing question worth deciding early is which market goes first. Brands with an existing UK retail relationship often clear the UK review first and treat the EU as the second, separately timed step; brands entering through an EU-based online channel frequently do the reverse. Either order can work — what does not work is assuming the second market's review is a formality once the first one is done.

A health claim on pack — a statement that a nutrient or product has a beneficial effect connected to health — is one of the most tightly controlled categories of wording in EU and UK supplement labelling, and it is also one of the easiest places for a brand brief to drift into territory a label review will send back. The caution this guide recommends is not "avoid saying anything interesting about the product." It is: treat any claim you want on pack as a compliance decision from the day you draft it, not a marketing decision you compliance-check afterward.

The practical discipline is to write your claim language against the accepted position for your destination market before it goes anywhere near a designer's file, rather than writing the claim that sounds strongest and hoping the label review approves it as written. A claim that has to be softened, reworded or removed after artwork is already built costs far more time than the same conversation held before a single file exists — and it is a conversation an artwork review is built to have with you early, not to catch you out with late.

This caution compounds across markets, not just within one: a claim wording accepted in one destination market is a starting point for reviewing the next one, never an automatic pass. A brand planning a multi-market EU launch should budget the claims-review conversation as its own step per market, the same way it budgets a separate notification check per market, rather than assuming one approved wording travels unchanged everywhere the product is sold.

Botanical ingredients occupy an unusually uncertain corner of the EU health-claims framework: a large group of claims connected to plant and botanical ingredients has sat pending a final union-level decision for years, which leaves individual member states applying their own, sometimes differing, national discretion in the meantime. A brand owner who reads that uncertainty as "botanicals are a looser category, so we have more room here" has read it backwards.

The safer reading is the opposite: because the final answer is not yet settled at union level, a botanical claim carries more market-by-market uncertainty than a claim already on the authorised list, not less. That means more caution in claim wording, not more room to experiment, and it means checking the specific national position for each destination market rather than assuming a botanical claim that reads fine in one country will read the same way in the next.

This is a case where the instinct to move fast should be resisted deliberately. A brand building a range around a botanical positioning benefits from treating claims review as an early, per-market conversation — ideally before the flavour and format decisions are even finalised — rather than a late check squeezed in before artwork goes to print. Uncertainty at the framework level is a reason to build in more review time, not a signal that the category is lightly regulated.

A supplement label sold across several EU member states is not one label translated into several languages after the fact — it is, functionally, a separate compliance document per language, because the ingredient declaration, allergen statement, nutrition information and any on-pack claim all need to read correctly, and mean the same thing, in each destination market's required language. Treating translation as a final production step, handled once the master-language version is signed off, is one of the more common ways a label review runs into last-minute delay.

The practical fix is to build language requirements into the artwork brief from the first draft, alongside the ingredient declaration and allergen statement, rather than designing one master file and asking for translations once everything else is locked. A label built with every required-language version in mind from the outset moves through review with far fewer rounds than one designed in a single language and adapted market by market afterward — and a translation correction is a much smaller adjustment before a design is finished than after it.

Language requirements also interact with claims and notification decisions, not just with the mechanics of layout: a claim wording accepted in one language needs the same accuracy of meaning, not just a literal word-for-word conversion, in every other required language on the pack. A brand entering several EU markets at once should treat the translated claim wording as part of the same per-market review as the claim itself, rather than a separate, purely linguistic task handled at the end.

The EU's novel food framework exists to review any ingredient, or any ingredient prepared in a genuinely new way, that does not have a documented history of significant consumption within the union before a fixed reference date. An ingredient that falls inside that framework needs authorisation before it can be sold, and that authorisation process runs on its own timeline, separate from your formulation or artwork schedule. The decision-journey lesson is simple: run the novel food question before the ingredient becomes the centrepiece of your brand concept, not after.

In practice this means treating an unusual, newly trending or recently popularised ingredient with the same early caution you would treat an unfamiliar claim: check its status before it anchors your positioning, your artwork or your marketing calendar. An ingredient with an unresolved novel food question is not necessarily off the table, but it is a genuinely different planning conversation than one already established in the union's food supply — different timeline, different risk, and a decision that should be made with that difference visible from the start, not discovered after a concept is already locked in.

This is a check worth running once per ingredient, not once per brand: a formula built from several less-common ingredients may need the novel food question asked of more than one component, not just the ingredient the brand positioning is built around. Running that check early, alongside the concept and claims decisions rather than after formulation is finished, keeps a genuinely interesting but unresolved ingredient from becoming a launch-date risk discovered too late to plan around.

Make it Yours covers approved flavour, colour and shape changes on an existing formula; changes to actives, amounts or claims move into a separately scoped Custom Formula R&D conversation, and naming or artwork still follow the standard private-label branding process regardless of route. That boundary matters for compliance planning specifically: a flavour, colour or shape change on an already-reviewed formula does not reopen the underlying ingredient or claims compliance picture, because the active composition has not changed.

A genuinely new claim, a changed active ingredient or a different amount, on the other hand, is a different compliance question every time, because it changes exactly the thing the notification, claims and, where relevant, novel food review was built to assess. Knowing which side of that boundary your brief sits on, before you write it, tells you whether your compliance review is largely a formality confirming an already-reviewed formula, or a genuinely new review that needs its own timeline.

This is a useful filter to apply honestly rather than optimistically: a brand owner who wants a new claim on an existing formula, and hopes a colour or flavour change can quietly carry that claim through, is asking a Custom Formula R&D question while budgeting for a Make it Yours one. Separating "which route is this" from "how much do I want it to cost" early avoids a mismatch between the compliance review a brief actually needs and the one it was scoped to receive.

DAT Supply's documentation set — specification, an artwork review against a destination market's stated requirements, and the batch Certificate of Analysis — is built to support a compliance decision, not to replace the judgement of a regulatory or legal specialist for a genuinely borderline case. A manufacturer's artwork review checks a label against what the destination market publicly requires; it does not substitute for specialist advice on a claim that sits close to a line, an ingredient with an unresolved novel food question, or entry into a jurisdiction the brand has never sold into before.

The practical test is whether the question is "does this documentation match what is required" or "is this specific claim, ingredient or market entry actually permitted." The first is a documentation-and-review question a manufacturer's process is built to support. The second is a judgement call that benefits from a specialist who tracks that specific market's current position, because national guidance shifts, and a manufacturer's documentation reflects what is required today, not a forecast of what a regulator decides tomorrow.

Knowing which of those two questions you are actually asking, before you ask it, is what keeps a brand owner from either over-relying on a manufacturer for judgement calls it was never positioned to make, or under-using the documentation a manufacturer genuinely does provide. Bring a specialist in early for anything that reads as a judgement call, and lean on the documentation set for everything that is a straightforward confirmation — treating the two as separate tools, not one continuous service, is what makes both actually useful.

Documentation is released by order stage rather than handed over all at once: specification confirmation early, an artwork review against the destination market's requirements before print, and a batch-specific Certificate of Analysis after production and quality-control release. The brand owner's job is to build a compliance file as each document actually arrives, rather than requesting everything retroactively once a retailer's compliance team, or a border authority, asks for it first.

The same logic applies to sequencing the compliance decisions themselves: settle destination markets and claim intent at the concept stage, run the notification and novel food questions once the formula is close to final, finish label language and the artwork review before a production order is placed, and file each piece of documentation as it is released rather than waiting for a single final packet. Each of those steps is genuinely sequential — jumping ahead, finalising artwork before the claims review for example, is how a compliance conversation ends up happening twice.

If there is one habit worth taking from this whole decision journey, it is treating compliance as a series of checkpoints you actively confirm, not a background process someone else is running for you. A brand owner who asks, at each stage, exactly what has been confirmed and what documentation supports it — rather than assuming a manufacturing relationship quietly covers the compliance question — is the brand owner who is not surprised later.

Read the country-by-country guidance for the markets you are actually entering, and treat every claim and label decision in this guide as the starting point for that market-specific check, not the end of it. Compliance ownership is not a single decision made once at launch; it is a habit you carry into every new market, every reformulation and every claim you consider adding for as long as the brand keeps growing.